Patents by Inventor Paul F. Life

Paul F. Life has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Inflammatory mediator antagonists
    Patent number: 8003101
    Abstract: The present invention relates to methods of reducing cartilage degradation in a patient comprising administering to a patient in need thereof an effective amount of an antibody antagonist to the mature form of OSM.
    Type: Grant
    Filed: May 9, 2007
    Date of Patent: August 23, 2011
    Assignee: GlaxoSmithKline LLC
    Inventors: Paul F. Life, Edward S. Rees, Andrew D. Rhodes
  • Inflammatory mediator antagonists
    Patent number: 7291332
    Abstract: The present invention relates to the use of an antagonist of OSM such as an antibody or small molecule in the manufacture of a medicament for the treatment or prophylaxis of an inflammatory arthropathy or inflammatory disorder, and the use of OSM in screening for such antagonists.
    Type: Grant
    Filed: October 27, 2005
    Date of Patent: November 6, 2007
    Assignee: SmithKline Beecham Corporation
    Inventor: Paul F. Life
  • Inflammatory mediator antagonists
    Publication number: 20040081650
    Abstract: The present invention relates to the use of an antagonist of OSM such as an antibody or small molecule in the manufacture of a medicament for the treatment or prophylaxis of an inflammatory arthropathy or inflammatory disorder, and the use of OSM in screening for such antagonists.
    Type: Application
    Filed: May 21, 2003
    Publication date: April 29, 2004
    Inventors: Paul F. Life, Edward S. Rees, Andrew D. Rhodes
  • Oncostatin M antagonists
    Patent number: 6706266
    Abstract: The present invention relates to the use of an antagonist of OSM such as an antibody or small molecule in the manufacture of a medicament for the treatment or prophylaxis of an inflammatory arthropathy or inflammatory disorder, and the use of OSM in screening for such antagonists.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: March 16, 2004
    Assignee: SmithKline Beecham Corporation
    Inventor: Paul F. Life